Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 3, 2000, Pages 233-238

  Stuschke, Martin ^a,b,c   Stahl, Michael ^a,b   Wilke, Hansjochen ^a,b   Walz, Martin ^a,b   Oldenburg, Anneruth ^a,b   Stüben, Georg ^a,b   Seeber, Siegfried ^a,b   Sack, Horst ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Kliniken Essen Mite   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Accelerated hyperfractionated radiotherapy; Brachytherapy; Concurrent radiochemotherapy; Esophageal cancer; Induction chemotherapy

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; THROMBOCYTOPENIA; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; SURVIVAL ANALYSIS;

EID: 0034442280     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200006000-00004     Document Type: Article

References (29)

1. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital
2. Comparison of three techniques of esophagectomy within a residence training program
3. Stage II esophageal carcinoma: The significance of T and N
4. Surgery of squamous cell carcinoma of the esophagus
5. Long-term results of infusional 5-FU. Mitomycin-C, and radiation as primary management of esophageal carcinoma
6. Curative non-surgical combined treatment of squamous cell carcinoma of the oesophagus
7. Treatment of squamous cell carcinoma of the esophagus with alternating radiotherapy and chemotherapy (cisplatin, methotrexate, peplomycin)
8. Treatment of advanced esophageal cancer by means of irradiation, cisplatinum and 5-fluorouracil
9. Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus
10. Unresectable nonmetastatic squamous cell carcinoma of the esophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapy
11. Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus
12. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma
13. Neoadjuvant chemotherapy and radiotherapy in locally advanced esophagus carcinoma: Long-term results
14. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: Interim analysis of a phase II trial
15. LENT SOMA scales for all anatomic sites - Esophagus
16. Reporting results of cancer treatment
17. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
18. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
19. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: A preliminary analysis of the phase II Intergroup trial 0122
20. Evaluation of multi-modality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060
21. Chemoradiotherapy of esophageal carcinoma
22. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity report
23. Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole, and cisplatin-fluorouracil, with or without surgery: Neurotoxicity, other toxicities and outcome
24. Nonoperative therapy for squamous-cell cancer of the esophagus
25. Neoadjuvant therapy for squamous cell esophageal carcinoma
26. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma
27. Accelerated fractionation in esophageal cancers: A multivariate analysis on 88 patients